These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1520886)

  • 1. Specific marrow ablation before marrow transplantation using an aminophosphonic acid conjugate 166Ho-EDTMP.
    Appelbaum FR; Brown PA; Sandmaier BM; Storb R; Fisher DR; Shulman HM; Graham TC; Schuening FG; Deeg HJ; Bianco JA
    Blood; 1992 Sep; 80(6):1608-13. PubMed ID: 1520886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow transplantation in dogs after radio-ablation with a new Ho-166 amino phosphonic acid bone-seeking agent (DOTMP).
    Parks NJ; Kawakami TG; Avila MJ; White R; Cain GR; Raaka SD; Hornoff W; Fisher P; Moore P; Seibert JA
    Blood; 1993 Jul; 82(1):318-25. PubMed ID: 8324232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethylene diamine tetramethylene phosphonic acid labeled with various β(-)-emitting radiometals: labeling optimization and animal biodistribution.
    Sohaib M; Ahmad M; Jehangir M; Perveen A
    Cancer Biother Radiopharm; 2011 Apr; 26(2):159-64. PubMed ID: 21510750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of samarium-153 and holmium-166-EDTMP in the normal baboon model.
    Louw WK; Dormehl IC; van Rensburg AJ; Hugo N; Alberts AS; Forsyth OE; Beverley G; Sweetlove MA; Marais J; Lötter MG; van Aswegen A
    Nucl Med Biol; 1996 Nov; 23(8):935-40. PubMed ID: 9004281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 153Sm-EDTMP and melphalan chemoradiotherapy regimen for bone marrow ablation prior to marrow transplantation: an experimental model in the rat.
    Turner JH; Claringbold PG; Berger JD; Martindale AA; Glancy JR
    Nucl Med Commun; 1992 May; 13(5):321-9. PubMed ID: 1603471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, dosimetry and toxicity of holmium-166-DOTMP for bone marrow ablation in multiple myeloma.
    Bayouth JE; Macey DJ; Kasi LP; Garlich JR; McMillan K; Dimopoulos MA; Champlin RE
    J Nucl Med; 1995 May; 36(5):730-7. PubMed ID: 7738641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic and genotoxic effect of the [166Dy]Dy/166Ho-EDTMP in vivo generator system in mice.
    Pedraza-López M; Ferro-Flores G; Arteaga de Murphy C; Morales-Ramírez P; Piedras-Ross J; Murphy-Stack E; Hernández-Oviedo O
    Nucl Med Biol; 2004 Nov; 31(8):1079-85. PubMed ID: 15607490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials.
    Giralt S; Bensinger W; Goodman M; Podoloff D; Eary J; Wendt R; Alexanian R; Weber D; Maloney D; Holmberg L; Rajandran J; Breitz H; Ghalie R; Champlin R
    Blood; 2003 Oct; 102(7):2684-91. PubMed ID: 12730103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiopharmaceutical therapy of 5T33 murine myeloma by sequential treatment with samarium-153 ethylenediaminetetramethylene phosphonate, melphalan, and bone marrow transplantation.
    Turner JH; Claringbold PG; Manning LS; O'Donoghue HL; Berger JD; Glancy RJ
    J Natl Cancer Inst; 1993 Sep; 85(18):1508-13. PubMed ID: 8360933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation dose distribution within the bone marrow of patients receiving holmium-166-labeled-phosphonate for marrow ablation.
    Bayouth JE; Macey DJ; Boyer AL; Champlin RE
    Med Phys; 1995 Jun; 22(6):743-53. PubMed ID: 7565363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetry and toxicity of samarium-153-EDTMP administered for bone pain due to skeletal metastases.
    Bayouth JE; Macey DJ; Kasi LP; Fossella FV
    J Nucl Med; 1994 Jan; 35(1):63-9. PubMed ID: 7505819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multispecies animal investigation on biodistribution, pharmacokinetics and toxicity of 177Lu-EDTMP, a potential bone pain palliation agent.
    Máthé D; Balogh L; Polyák A; Király R; Márián T; Pawlak D; Zaknun JJ; Pillai MR; Jánoki GA
    Nucl Med Biol; 2010 Feb; 37(2):215-26. PubMed ID: 20152721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous study of the biodistribution of radio-yttrium complexed with EDTMP and citrate ligands in tumour-bearing rats.
    Beyer GJ; Bergmann R; Kampf G; Mäding P; Rösch F
    Int J Rad Appl Instrum B; 1992 Feb; 19(2):201-3. PubMed ID: 1601673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (170)Tm-EDTMP: a potential cost-effective alternative to (89)SrCl(2) for bone pain palliation.
    Das T; Chakraborty S; Sarma HD; Tandon P; Banerjee S; Venkatesh M; Pillai MR
    Nucl Med Biol; 2009 Jul; 36(5):561-8. PubMed ID: 19520297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of (166)Dy/(166)Ho-EDTMP: a potential in vivo generator system for bone marrow ablation.
    Pedraza-López M; Ferro-Flores G; de Murphy CA; Tendilla JI; Villanueva-Sánchez O
    Nucl Med Commun; 2004 Jun; 25(6):615-21. PubMed ID: 15167523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [166Dy]dysprosium/[166Ho]holmium in vivo generator.
    Smith SV; Di Bartolo N; Mirzadeh S; Lambrecht RM; Knapp FF; Hetherington EL
    Appl Radiat Isot; 1995 Aug; 46(8):759-64. PubMed ID: 7633391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I study of samarium-153 ethylenediaminetetramethylene phosphonate therapy for disseminated skeletal metastases.
    Turner JH; Claringbold PG; Hetherington EL; Sorby P; Martindale AA
    J Clin Oncol; 1989 Dec; 7(12):1926-31. PubMed ID: 2585026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the [(153)Sm]Sm-EDTMP pharmacokinetics and estimation of radiation absorbed dose on an individual basis.
    Vigna L; Matheoud R; Ridone S; Arginelli D; Della Monica P; Rudoni M; Inglese E; Brambilla M
    Phys Med; 2011 Jul; 27(3):144-52. PubMed ID: 20864370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marrow irradiation with high-dose 153Samarium-EDTMP followed by chemotherapy and hematopoietic stem cell infusion for acute myelogenous leukemia.
    Rodriguez V; Anderson PM; Litzow MR; Erlandson L; Trotz BA; Arndt CA; Khan SP; Wiseman GA
    Leuk Lymphoma; 2006 Aug; 47(8):1583-92. PubMed ID: 16966270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicities of 166Holmium-chitosan in mice.
    Lee WY; Moon EY; Lee J; Choi CH; Nam SC; Park KB; Ryu JM; Chung YH; Yoon SJ; Lee DK
    Arzneimittelforschung; 1998 Mar; 48(3):300-4. PubMed ID: 9553690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.